GlassScriptPhysician profile
Caitlin Stritch
NPI 1184262008
$644.44
in general payments reported to CMS, 2019-2025
15 companies · $333 in 2025
The $333 reported for 2025 was more than what 87% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $74.32 · 2024: $238 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $163.66 | 2023-2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $84.73 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $62.03 | 2025 | |
| Pfizer INC. | $56.37 | 2024-2025 | |
| Ironshore Pharmaceuticals INC. | $51.89 | 2024 | |
| Merck Sharp & Dohme LLC | $48.50 | 2024-2025 | Vaxelis, Gardasil 9, Proquad |
| Cranial Technologies, INC | $47.15 | 2024-2025 | Doc Band |
| Sobi, INC | $21.30 | 2023 | |
| Lnhc, INC | $16.49 | 2025 | Zelsuvmi |
| Avion Pharmaceuticals | $16.19 | 2023 | Methylphenidate Hydrochloride |
| Cipher Pharmaceuticals US LLC | $15.96 | 2025 | Spinosad, Natroba |
| Vertical Pharmaceuticals, LLC | $15.72 | 2024 | Relexxii |
| Glaxosmithkline, LLC. | $15.25 | 2023 | Menveo, Bexsero |
| Exeltis, USA INC. | $14.61 | 2025 | Slynd |
| Azurity Pharmaceuticals, INC. | $14.59 | 2025 | Alvesco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Stritch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.